Clinical trial
Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS
NCT00003790 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 1995
- Completion date
- September 30, 2006
- Enrollment
- 496 (actual)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.